Sentieon provides the most accurate, consistent, and efficient software for processing genomic data. This has been demonstrated in awards on the precisionFDA platform challenges for accuracy and consistency analyzing data sets of NA12878 and NA24385. Sentieon also finished first in the ICGC-TCGA Dream Challenge for Somatic Mutation Detection in each category, somatic detection of SNV, INDEL, and SV.Contact me anytime to start taking advantage of our award winning software or check it out via our partners, Fabric Genomics, DNAnexus, Golden Helix, Omicsoft, and DNAstack.

Updated Ikamva’s corporate governance and organizational policies by auditing their current policies, benchmarking against best practices, and conducting interviews with management.

Worked with a major pharmaceutical company to facilitate organizational change within their clinical trial management system by instituting activity based costing, through process improvement, and software integration.Participated in project management, incorporating client and team feedback to keep the project on schedule and in scope.

European and FDA approval for the oncology drug Lutathera! Acquired by AAAP and then NovartisI completed research and study reports included in applications to the FDA to start human clinical trials; the IND has been approved and the drug is now approved in Europe with a decision from the FDA in January 2018. For more info check out this link on Lutathera http://www.adacap.com/netter-1/Conducted research for inclusion in the Orphan Drug Document which was approved by the FDA and created market exclusivity for seven years along with millions of dollars in tax credits.Developed FDA compliant and efficient analytical standard protocols using a variety of instruments to identify and quantify the individual components of BioSynthema’s lead oncology therapeutic, Lutathera, which is now approved in Europe.

Worked to measure brain-derived neurotrophic factor protein expression to infrom the effect of exercise on primate neuron growth

Isolated and sequenced novel promoters in mammalian DNA to modify gene expression

Investigated the potential for Alu elements to homologously recombine, causing deletions in the human genome.

Key Word SearchLife Sciences, Sales, Sales Operations, Sales Management, Customer Relationship Management, Field Sales, Outside Sales, Territory Manager, Project Management, Cost Reduction, Procurement, Business Integration, Software Integration, Consulting, Managed Care, Marketing Analytics, Performance Dashboard, Consultative Selling, Strategic Planning, Business Development, Vendor, Strategic Alliances, Market Development, Next Generation Sequencing, NGS, Laboratory, Inside Sales, Technology, SaaS, software-as-a-service, Business Plans, Start Ups, Growth, Voice of Customer, VoC, Competitive Analysis, Pharmaceutical, Molecular Biology, Cellular, Genomics, Genetic, Molecular Diagnostics, Oncology, Gastro-Entero-Pancreatic Neuroendocrine Tumors, GEP-Net, MBA